Evidence map›Paper›PMID 38094240›Full record

ReviewEngineering biology2023

Israel and the global synthetic biology ecosystem.

Yuval Dorfan, Aviv Zeevi, Gita Reinitz, Magi Mualem, Yosi Shacham-Diamand

Abstract readReview
In one paragraph

Review in Engineering biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yuval DorfanBioengineering HIT Holon Israel.ORCID https://orcid.org/0000-0003-3236-0572
Aviv ZeeviIsraeli Innovation Authority Jerusalem Israel.
Gita ReinitzNFX.Bio Herzliya Israel.
Magi MualemShamir Research Institute Katzrin Israel.
Yosi Shacham-DiamandScojen Institute of Synthetic Biology Reichmann University Herzliya Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The field of synthetic biology emerged a few decades ago, following some key works of researchers in the USA, Europe, and the Far East. It reached Israel through academia and a few years later it finally got the attention of industry, venture capitals, and government authorities, especially the Israeli Innovation Authority, hoping to encourage entrepreneurs to establish startups in this field. Here we provide an overview of the activity of the field of synthetic biology in Israel, including historical notes, current strategy, prospects and developments, and further insight that are relevant to any stakeholders in the synthetic biology field.

Indexed as

automationbio‐designbio‐economybiomaterialsbioprocess engineeringbiosensorsgenertic systemsgenetic circuitsmicrobial engineeringsynthetic biology

Identifiers

PMID38094240
PMCPMC10715126

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.